טוען...
Retreatment Options Following HCV Direct Acting Antiviral Failure
Despite the excellent efficacy of direct acting antivirals (DAA) for hepatitis C virus (HCV), treatment failures do occur. Until recently, retreatment decisions after DAA failure were influenced by the number of available agents, concerns about HCV drug resistance, and lack of data regarding retreat...
שמור ב:
| הוצא לאור ב: | Curr Treat Options Infect Dis |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5726279/ https://ncbi.nlm.nih.gov/pubmed/29242710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40506-017-0136-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|